1. Market Research
  2. > Pharmaceutical
  3. > Drug Development Market Trends
  4. > Drug Development Analysis & Statistics 2020 - Europe

Drug Development Analysis & Statistics 2020 - Europe

1-30 of 57 reports

Coronavirus Disease 2019 (COVID-19) Pandemic Impact on Clinical Trials

  • $ 1495
  • August 2020
  • 52 pages

Coronavirus Disease 2019 (COVID-19) Pandemic Impact on Clinical Trials Summary This PowerPoint based report gives an important expert analysis on how COVID-19 is impacting clinical trials and the potential ...

  • Clinical Trial
  • Drug Development
  • Pharmaceutical
  • Europe
  • World

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 - Pipeline Review, H1 2020

  • $ 3500
  • April 2020
  • 53 pages

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 - Pipeline Review, H1 2020 Summary Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 (GABA(A) Receptor Subunit Gamma 2 or GABRG2) pipeline Target constitutes ...

  • Drug Development
  • Pharmaceutical
  • China
  • Europe
  • PAION AG

The Life Sciences Fast Track to Combatting COVID-19 in Europe: Intelligent Collaboration at Scale

  • $ 4500
  • April 2020
  • 13 pages

This IDC Perspective analyzes the role of ICT in supporting life sciences companies in the fight against COVID-19, highlighting early experiences from companies operating in Europe and worldwide. The study ...

  • Drug Development
  • Health Services
  • Laboratory
  • Europe
  • Company Operations

Europe Healthcare CRO Services Market By Service Type By End User By Therapeutic Area By Country, Industry Analysis and Forecast, 2019 - 2025

  • $ 1500
  • March 2020
  • 108 pages

The Europe Healthcare CRO Market would witness market growth of 5.9% CAGR during the forecast period (2019-2025). Healthcare project management helps companies improve and function more efficiently in ...

  • Drug Development
  • Healthcare
  • Pharmaceutical
  • Europe

European Life Sciences Key IT Deals and Initiatives Update, Q4 2019

  • $ 4500
  • March 2020
  • 10 pages

This IDC Market Perspective provides IDC Health Insights' review of key IT deals, news, and digital initiatives in European life sciences and pharma in Q4 2019. In the evolving industry environment in ...

  • Drug Development
  • Pharmaceutical
  • Therapy
  • Europe
  • Supply

Global Compound Management Industry

  • $ 4950
  • February 2020
  • 134 pages

Compound Management market worldwide is projected to grow by US$337.9 Million, driven by a compounded growth of 14.7%. Instruments, one of the segments analyzed and sized in this study, displays the potential ...

  • Drug Development
  • Europe
  • World
  • Market Shares

Admedus Ltd (AHZ) - Product Pipeline Analysis, 2019 Update

  • $ 750
  • January 2020
  • 54 pages

Summary Admedus Ltd (Admedus) develops, manufactures and distributes medical devices and technologies with focus on tissue engineering and immunotherapies.Using its proprietary ADAPT engineering process, ...

  • Clinical Trial
  • Drug Development
  • Europe
  • Demand
  • Admedus Ltd

Europe Contract Research Organization Market to 2025 - Regional Analysis and Forecasts By Type ; End User, and Country

  • $ 3000
  • January 2020
  • 151 pages

Contract research organization (CRO) market in Europe is expected to grow from US$ 12,476.8Mn in the year 2017 and is expected to reach US$ 22,157.62 Mn by 2025 growing at a healthy CAGR for the forecast ...

  • Drug Development
  • Europe
  • Forecast
  • Market Size
  • PAREXEL International Corporation

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 - Pipeline Review, H2 2019

  • $ 3500
  • December 2019
  • 53 pages

Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 - Pipeline Review, H2 2019 Summary According to the recently published report ’Gamma-Aminobutyric Acid Receptor Subunit Gamma 2 - Pipeline Review, H2 ...

  • Drug Development
  • Pharmaceutical
  • Europe
  • United States
  • PAION AG

Protein Glutamine Gamma Glutamyltransferase 2 - Pipeline Review, H2 2019

  • $ 3500
  • November 2019
  • 38 pages

Protein Glutamine Gamma Glutamyltransferase 2 - Pipeline Review, H2 2019 Summary According to the recently published report ’Protein Glutamine Gamma Glutamyltransferase 2 - Pipeline Review, H2 2019’; ...

  • Drug Development
  • Europe
  • World
  • Product Initiative
  • Catabasis Pharmaceuticals, Inc.

Somahlution Inc - Product Pipeline Analysis, 2019 Update

  • $ 750
  • November 2019
  • 30 pages

Summary Somahlution Inc (Somahlution) is a biotechnology company that offers discovery, development and commercialization of innovative solutions to advance clinical performance.The company offers duragraft, ...

  • Drug Development
  • Health Services
  • Hospital
  • Europe
  • Product Initiative

MagForce AG (MF6) - Product Pipeline Analysis, 2019 Update

  • $ 750
  • November 2019
  • 37 pages

Summary MagForce AG (MagForce) is a medical device company that offers nanotechnology-based therapy for cancer treatment.The company’s products include NanoActivator, NanoTherm, NanoPlan and NanoTherm ...

  • Drug Development
  • Europe
  • United States
  • Company
  • MagForce AG

Europe Compound Management Market to 2027 - Regional Analysis and Forecasts by Product & Services, Sample Type, Application, End User and Country.

  • $ 3000
  • September 2019
  • 153 pages

The Europe compound management market is expected to reach US$ 192.77 Mn in 2027 from US$ 60.32 Mn in 2018. This market is projected to grow at a growth rate of 14.5% from 2019-2027. The growth of the ...

  • Drug Development
  • Europe
  • Forecast
  • Market Size
  • Icagen, Inc.

EUROPE DRUG DISCOVERY MARKET FORECAST 2019-2027

  • $ 1250
  • August 2019
  • 92 pages

KEY FINDINGS The Asia-Pacific machine learning market is predicted to contribute $XX million by 2027 while registering the CAGR of 32.92% in the global market by the end of the forecast period of 2019-2027. ...

  • Drug Development
  • Europe
  • Market Size

EUROPE PHARMACEUTICAL DESICCANT MARKET FORECAST 2019-2027

  • $ 1250
  • August 2019
  • 62 pages

KEY FINDINGS The Asia Pacific drug discovery market is predicted to flourish with CAGR of 8.97% between the forecast period of 2019 and 2027. The Asia Pacific market is estimated to generate a revenue ...

  • Drug Development
  • Pharmaceutical
  • Europe

Global High Content Screening (HCS) Industry

  • $ 5600
  • May 2019
  • 194 pages

This report analyzes the worldwide markets for High Content Screening (HCS) in US$ Million. The Global market is further analyzed by the following Segments: Consumables, Instruments, and Others. The ...

  • Drug Development
  • APAC
  • Europe
  • World
  • Company Financials

Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H1 2019

  • $ 3500
  • April 2019
  • 36 pages

Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, ...

  • Drug Development
  • Europe
  • World
  • Product Initiative
  • Catabasis Pharmaceuticals, Inc.

EUROPE CLINICAL TRIAL MANAGEMENT MARKET FORECAST 2019-2027

  • $ 1250
  • April 2019
  • 87 pages

KEY FINDINGS Pharmaceutical and biopharmaceutical companies utilize clinical trial management systems for the management and maintenance of clinical trials data obtained from various research activities. ...

  • Clinical Trial
  • Drug Development
  • Europe

In Vitro ADME Testing Services Market, 2019-2030

  • $ 3999
  • January 2019
  • 317 pages

INTRODUCTION The early stages of drug discovery research, which include the identification of a relevant biological target and a viable lead compound with therapeutic potential, play a crucial role in ...

  • Drug Development
  • Pharmaceutical
  • Europe
  • World
  • M&A

Vexim SA - Product Pipeline Analysis, 2018 Uate

  • $ 750
  • December 2018
  • 27 pages

Summary Vexim SA (Vexim), a subsidiary of Stryker Corp, is a healthcare product manufacturer that provides solutions for patients suffering from vertebral compression fractures.The company provides solutions ...

  • Drug Development
  • Prosthesis
  • Europe
  • Demand
  • VEXIM

numares AG - Product Pipeline Analysis, 2018 Update

  • $ 750
  • December 2018
  • 39 pages

Summary Numares AG (Numares), formerly Numares GmbH, is a developer and marketer of products for life science research and clinical diagnostics.The company’s AXINON lipoFIT, a test system used for lipoprotein ...

  • Clinical Trial
  • Diagnostics
  • Drug Development
  • Europe
  • Product Initiative

Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • October 2018
  • 46 pages

Summary Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research organization that offers drug development, clinical trial management and resourcing ...

  • Drug Development
  • Pharmaceutical
  • Europe
  • M&A
  • Venn Life Sciences Holdings Plc

Medical Device CROs Market

  • $ 3499
  • October 2018
  • 325 pages

INTRODUCTION According to the World Bank, more than 50,000 different types of medical devices are currently being used every day in health care facilities worldwide. In 2018, the global medical devices ...

  • Drug Development
  • Medical Device
  • Medical Equipment
  • Medical Supply
  • Europe

NeuroDerm Ltd - Product Pipeline Analysis, 2018 Update

  • $ 750
  • September 2018
  • 39 pages

Summary NeuroDerm Ltd (NeuroDerm), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a pharmaceutical company that develops of drugs for the treatment of Parkinson’s disease and central nervous system ...

  • Drug Development
  • Europe
  • Company Operations
  • Product Initiative
  • NeuroDerm Ltd.

Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018

  • $ 3500
  • July 2018
  • 37 pages

Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, ...

  • Drug Development
  • Pharmaceutical
  • Therapy
  • Europe
  • Product Initiative

Vectura Group Plc (VEC) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • June 2018
  • 36 pages

Summary Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform.It develops inhalation products, to help patients ...

  • Clinical Trial
  • Drug Development
  • Europe
  • Company Financials
  • Vectura Group plc

LifeBond Ltd - Product Pipeline Analysis, 2018 Update

  • $ 750
  • June 2018
  • 25 pages

Summary LifeBond Ltd (LifeBond) is a medical device company that develops and manufactures devices for bio-surgery and tissue repair devices.The company offers products such as lifeseal surgical sealant ...

  • Drug Development
  • Hospital
  • Sealant
  • Europe
  • LifeBond Ltd.

Travel Vaccines: A US and European Perspective

  • $ 7995
  • May 2018
  • 117 pages

Travel Vaccines: A US and European Perspective Summary As the cost of travel has decreased, more and more people are choosing to travel abroad for business and leisure.As a result, they can be exposed ...

  • Drug Development
  • Therapy
  • Vaccine
  • Europe
  • Product Initiative

Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) - Pipeline Review, H1 2018

  • $ 3500
  • March 2018
  • 55 pages

Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) - Pipeline Review, H1 2018 Summary According to the recently published report ’Histamine ...

  • Drug Development
  • Ear Disease
  • Molecular Diagnostics
  • Europe
  • Sensorion S.A.

Pontine Glioma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H1 2018

  • $ 1200
  • February 2018
  • 100 pages

Glioma clinical trials report from VPA Research provides comprehensive analysis and trends in global Glioma disease clinical trials. The research work analyzes the evolution of Glioma clinical trial trends ...

  • Clinical Trial
  • Drug Development
  • Europe
  • Company Operations
  • Product Initiative

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on